- Universal hepatitis B vaccination is likely to decrease the incidence ofÂ hepatocellular carcinoma worldwide.

- Direct antiviral for the treatment of chronic hepatitis C cirrhosis and the achievement of sustained viral response is likely to decrease the incidence of HCC.

- Non-cirrhotic chronic hepatitis B virus infection with high-risk for the development of HCC include patients with elevated ALT and high serum hepatitis B virus DNA, family history of HCC, patients older than age 20 years from sub-Saharan Africa, Asian men and women older than 40 and 50 years should undergo surveillance.

- Surveillance with ultrasound and with or without alpha-fetoprotein every 4-6 months is likely to increase the detection of early HCC.